Howard G. Welgus's most recent trade in Arcutis Biotherapeutics Inc was a trade of 10,139 Common Stock done at an average price of $13.4 . Disclosure was reported to the exchange on June 18, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 13.37 per share. | 18 Jun 2025 | 10,139 | 109,414 (0%) | 0% | 13.4 | 135,574 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 20,568 | 20,568 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2025 | 7,609 | 119,553 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 14.64 per share. | 01 May 2025 | 10,000 | 111,944 (0%) | 0% | 14.6 | 146,357 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 15.12 per share. | 01 Apr 2025 | 10,000 | 121,944 (0%) | 0% | 15.1 | 151,236 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 13.00 per share. | 03 Mar 2025 | 10,000 | 131,944 (0%) | 0% | 13.0 | 130,048 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 12.71 per share. | 03 Feb 2025 | 10,000 | 141,944 (0%) | 0% | 12.7 | 127,100 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 14.67 per share. | 02 Jan 2025 | 10,000 | 151,944 (0%) | 0% | 14.7 | 146,714 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 12.51 per share. | 02 Dec 2024 | 10,000 | 161,944 (0%) | 0% | 12.5 | 125,133 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 8.65 per share. | 01 Nov 2024 | 10,000 | 171,944 (0%) | 0% | 8.7 | 86,541 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 9.26 per share. | 01 Oct 2024 | 10,000 | 181,944 (0%) | 0% | 9.3 | 92,616 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 10.77 per share. | 03 Sep 2024 | 10,000 | 191,944 (0%) | 0% | 10.8 | 107,695 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 9.87 per share. | 01 Aug 2024 | 6,614 | 180,339 (0%) | 0% | 9.9 | 65,278 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Aug 2024 | 6,614 | 0 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 01 Aug 2024 | 6,614 | 186,953 (0%) | 0% | 1.7 | 11,115 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 9.87 per share. | 01 Aug 2024 | 3,386 | 176,953 (0%) | 0% | 9.9 | 33,418 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 9.31 per share. | 01 Jul 2024 | 10,000 | 180,339 (0%) | 0% | 9.3 | 93,141 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 01 Jul 2024 | 5,681 | 186,020 (0%) | 0% | 1.7 | 9,547 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 5,681 | 0 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2024 | 4,319 | 6,614 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 01 Jul 2024 | 4,319 | 190,339 (0%) | 0% | 1.7 | 7,259 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 27,052 | 27,052 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2024 | 10,139 | 180,339 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 04 Jun 2024 | 6,458 | 180,200 (0%) | 0% | 1.7 | 10,853 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 6,458 | 0 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 8.01 per share. | 04 Jun 2024 | 6,458 | 170,200 (0%) | 0% | 8.0 | 51,756 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jun 2024 | 3,542 | 5,681 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 04 Jun 2024 | 3,542 | 176,658 (0%) | 0% | 8 | 28,336 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 04 Jun 2024 | 3,542 | 173,742 (0%) | 0% | 1.7 | 5,953 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 12,220 | 12,220 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2023 | 4,375 | 170,200 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Apr 2023 | 8,500 | 6,458 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 17 Apr 2023 | 8,500 | 174,325 (0%) | 0% | 1.7 | 14,285 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 13.97 per share. | 17 Apr 2023 | 8,500 | 165,825 (0%) | 0% | 14.0 | 118,728 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Apr 2023 | 8,500 | 14,958 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 12.01 per share. | 06 Apr 2023 | 8,500 | 165,825 (0%) | 0% | 12.0 | 102,085 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 06 Apr 2023 | 8,500 | 174,325 (0%) | 0% | 1.7 | 14,285 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Feb 2023 | 8,500 | 23,458 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 16.98 per share. | 15 Feb 2023 | 8,500 | 165,825 (0%) | 0% | 17.0 | 144,352 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 15 Feb 2023 | 8,500 | 174,325 (0%) | 0% | 1.7 | 14,285 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 13.72 per share. | 17 Jan 2023 | 8,500 | 165,825 (0%) | 0% | 13.7 | 116,655 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jan 2023 | 8,500 | 31,958 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 17 Jan 2023 | 8,500 | 174,325 (0%) | 0% | 1.7 | 14,280 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 20.01 per share. | 15 Nov 2022 | 3,403 | 165,825 (0%) | 0% | 20.0 | 68,103 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 15 Nov 2022 | 1,020 | 169,228 (0%) | 0% | 1.7 | 1,714 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Nov 2022 | 1,020 | 40,458 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 20.29 per share. | 04 Oct 2022 | 6,000 | 168,208 (0%) | 0% | 20.3 | 121,766 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 24.80 per share. | 15 Aug 2022 | 6,000 | 174,208 (0%) | 0% | 24.8 | 148,789 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 24.40 per share. | 18 Jul 2022 | 6,000 | 180,208 (0%) | 0% | 24.4 | 146,374 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 11,796 | 11,796 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2022 | 4,312 | 186,208 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 20.62 per share. | 01 Jun 2022 | 2,500 | 181,896 (0%) | 0% | 20.6 | 51,539 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2022 | 2,500 | 41,478 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 01 Jun 2022 | 2,500 | 184,396 (0%) | 0% | 1.7 | 4,202 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 20.44 per share. | 02 May 2022 | 2,500 | 181,896 (0%) | 0% | 20.4 | 51,112 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2022 | 1,496 | 6,110 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.58 per share. | 02 May 2022 | 1,496 | 183,392 (0%) | 0% | 0.6 | 868 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2022 | 1,004 | 43,978 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 02 May 2022 | 1,004 | 184,396 (0%) | 0% | 1.7 | 1,687 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 20.02 per share. | 01 Apr 2022 | 7,500 | 181,896 (0%) | 0% | 20.0 | 150,184 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 7,500 | 7,606 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.58 per share. | 01 Apr 2022 | 7,500 | 189,396 (0%) | 0% | 0.6 | 4,352 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 21.21 per share. | 03 Jan 2022 | 2,500 | 181,896 (0%) | 0% | 21.2 | 53,030 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.58 per share. | 03 Jan 2022 | 2,500 | 184,396 (0%) | 0% | 0.6 | 1,451 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2022 | 2,500 | 15,106 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Dec 2021 | 2,500 | 17,606 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 20.16 per share. | 23 Dec 2021 | 2,500 | 181,896 (0%) | 0% | 20.2 | 50,396 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.58 per share. | 23 Dec 2021 | 2,500 | 184,396 (0%) | 0% | 0.6 | 1,451 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 21.81 per share. | 01 Nov 2021 | 2,500 | 181,896 (0%) | 0% | 21.8 | 54,524 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 2,500 | 20,106 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.58 per share. | 01 Nov 2021 | 2,500 | 184,396 (0%) | 0% | 0.6 | 1,451 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 23.87 per share. | 01 Oct 2021 | 2,500 | 181,896 (0%) | 0% | 23.9 | 59,680 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.58 per share. | 01 Oct 2021 | 2,500 | 184,396 (0%) | 0% | 0.6 | 1,451 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Oct 2021 | 2,500 | 22,606 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 4,444 | 9,223 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 01 Sep 2021 | 4,444 | 186,896 (0%) | 0% | 1.7 | 7,469 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 20.71 per share. | 01 Sep 2021 | 4,200 | 182,696 (0%) | 0% | 20.7 | 86,966 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 21.28 per share. | 01 Sep 2021 | 800 | 181,896 (0%) | 0% | 21.3 | 17,020 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.58 per share. | 01 Sep 2021 | 556 | 182,452 (0%) | 0% | 0.6 | 323 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2021 | 556 | 25,106 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 26.03 per share. | 01 Jul 2021 | 1,950 | 182,146 (0%) | 0% | 26.0 | 50,757 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.52 per share. | 01 Jul 2021 | 1,028 | 184,096 (0%) | 0% | 6.5 | 6,705 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 1,028 | 9,862 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 01 Jul 2021 | 781 | 183,068 (0%) | 0% | 1.7 | 1,313 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 781 | 23,428 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 01 Jul 2021 | 391 | 182,287 (0%) | 0% | 1.7 | 657 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 391 | 10,933 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 26.88 per share. | 01 Jul 2021 | 250 | 181,896 (0%) | 0% | 26.9 | 6,719 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2021 | 13,391 | 13,391 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 27.06 per share. | 01 Jun 2021 | 2,058 | 212,695 (0%) | 0% | 27.1 | 55,682 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.52 per share. | 01 Jun 2021 | 1,029 | 214,753 (0%) | 0% | 6.5 | 6,711 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 1,029 | 10,890 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 01 Jun 2021 | 781 | 213,724 (0%) | 0% | 1.7 | 1,313 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 781 | 24,209 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.68 per share. | 01 Jun 2021 | 390 | 212,943 (0%) | 0% | 1.7 | 655 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jun 2021 | 390 | 11,324 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 27.61 per share. | 01 Jun 2021 | 142 | 212,553 (0%) | 0% | 27.6 | 3,920 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 34.56 per share. | 03 May 2021 | 1,283 | 211,858 (0%) | 0% | 34.6 | 44,339 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 May 2021 | 1,028 | 11,919 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.52 per share. | 03 May 2021 | 1,028 | 213,141 (0%) | 0% | 6.5 | 6,705 | Common Stock |
| Arcutis Biotherapeutics Inc | Howard G. Welgus | Director | Sale of securities on an exchange or to another person at price $ 35.12 per share. | 03 May 2021 | 917 | 210,941 (0%) | 0% | 35.1 | 32,209 | Common Stock |